New Delhi: Agilent Technologies has announced the fourth edition of the Total Agilent Experience (TAE) 2021, hosted virtually this year by Agilent India from 7th July until 9th July.
In addition to showcasing Agilent’s latest analytical solutions, the symposium featured industry speakers who highlighted emerging trends in food, pharma, and biopharma industries, and provided a forum for 1-to-1 connections with Agilent’s technical teams through virtual interactive smart features.
“The Total Agilent Experience offers an excellent opportunity for scientists and industry experts to discuss new ways of solving emerging challenges and making their laboratories more efficient,” said Samir Vyas, Country Manager for Agilent in India. He further remarks, “The virtual symposium featured interactive workshops to demonstrate technology advancements that enable our customers to work on challenging applications with improved performance and ease of use, while also increasing laboratory productivity and economic value.”
Participants had the opportunity to attend live and on-demand sessions featuring advanced analytical solutions for emerging contaminants in food , mutagenic impurities in pharmaceuticals, biopharmaceutical process related impurities, new methodologies in microplastics analysis, new sophisticated Raman technology for use in pharmaceutical applications, and many more.
On display at the symposium were Agilent’s latest chromatography, mass spectrometry, and spectroscopy platforms, including:
The new, innovative Agilent 7850 ICP-MS System, provides new smart tools to minimize common time traps that can affect ICP-MS analysis workflows, thus reducing wasted time and provides solutions for higher productivity and efficiency without sacrificing quality results.
Agilent’s newly launched NanoDis System provides formulation scientists with accurate release profiles of APIs using conventional dissolution apparatus in an automated, compliant manner. This functionality enables analysts to uncover optimum nanoparticle formulation faster and get new drug formulations to market more quickly.
Agilent’s InfinityLab Poroshell 120 superficially porous columns for reversed-phase LC separations offer exceptional efficiency, reliability, and improved throughput. Packed with 4 μm, these columns provide the high-resolution separations to purify complex samples.
Agilent’s three InfinityLab Bio LC systems complement Agilent’s existing InfinityLab Bio LC portfolio. It’s designed to help labs by providing a future-proof, universal solution that delivers LC performance with additional bioanalysis capability and even higher durability to harsh analytical conditions.